| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.71B | +65.2% |
| Cost of Revenue | $677.2M | +120.9% |
| R&D Expense | $1.32B | +17.2% |
| SG&A Expense | $1.21B | +24.1% |
| Operating Income | $501.6M | +383.6% |
| Pre-tax Income | $323.2M | +185.6% |
| Income Tax | $9.4M | +109.5% |
| Net Income | $313.7M | +212.8% |
| EPS (Basic) | $2.39 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.66B | +71.5% |
| Accounts Receivable | $777.6M | +91.8% |
| Inventory | $82.7M | +5.4% |
| Current Assets | $4.05B | +22.9% |
| Total Assets | $4.97B | +17.1% |
| Current Liabilities | $1.47B | +23.6% |
| Total Liabilities | $4.18B | +0.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $524.1M | +6405.1% |
| Capital Expenditures | $58.7M | +71.2% |
| Investing Cash Flow | $436.3M | +473.4% |
| Financing Cash Flow | -$305.2M | -203.8% |
| Free Cash Flow | $465.4M | +1192.7% |
| +209.6% |
| EPS (Diluted) | $2.33 | +206.9% |
| Stockholders' Equity |
| $789.2M |
| +1076.3% |